Navigation Links
bioMETRX, Inc. Introduces New Products
Date:5/6/2008

smartTOUCH brand now includes hi-tech gun and storage chest

JERICHO, N.Y., May 6 /PRNewswire-FirstCall/ -- bioMETRX, Inc. (OTC Bulletin Board: BMRX), today announced that it has added two new products to its smartTOUCH product line, the bioVAULT and bioBOX, which are immediately available at retailers and online specialty sites.

"We are excited to offer these two new products as we grow our smartTOUCH product line of consumer based finger activated products. We have implemented a comprehensive integration and sales plan for these two established products which have been acquired as part of our deal to acquire the assets of the former Sequiam company. We have secured inventory necessary to fulfill outstanding orders, as well as to place these products into our existing channels through our partners," stated Lorraine Yarde, COO at bioMETRX.

The smartTOUCH bioVAULT is a rugged, heavy duty safe approved and licensed by the NRA that has successfully passed United States Test Laboratory (USTL) test(s) as required by California Penal Code Sections 12088 and Regulation Section 977.45, Chapter 12.6, Division 1, Title 11, of the California Code of Regulations. The VAULT requires its owner to first scan a finger before the VAULT can be opened. The smartTOUCH bioBOX is a smaller, portable version of the bioVAULT that is perfect to use as a cash box, or a personal effects security device. Both products are available through the Sharper Image, as well as the company's website at http://www.smarttouchstore.com

As the global leader in consumer biometric product engineering, development and sales, smartTOUCH technology has proven to be the most dependable and robust consumer biometric platform available today. The smartTOUCH product line is now being expanded to door locks, cabinet locks, mailboxes and luggage.

About bioMETRX, Inc.

bioMETRX, Inc. is rapidly becoming the le
'/>"/>

SOURCE bioMETRX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. bioMETRX, Inc. Calls Series B Warrants
2. bioMETRX, Inc. Acquires Patent for Biometric Padlock
3. bioMETRX, Inc. Acquires Patent for Biometric Padlock
4. bioMETRX, Inc. Announces Integration of AuthenTec Fingerprint Sensor in smartTOUCH(TM) Product Line
5. bioMETRX, Inc. Closes Angel Round of Funding
6. Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture
7. IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments
8. Missouri Police Department Introduces Electronic Traffic Citations
9. Silex Introduces Worlds First Wireless USB Device Server With Streaming Video and Audio Data Transfer
10. Web-Hosted Attendance on Demand(R) Introduces Innovative Web Time Clock
11. ETH Zurich competence center ESC introduces energy strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
(Date:7/8/2015)... NEW YORK , July 8, 2015 ... cancer globally, and the fourth most fatal, with a ... year. The poor prognosis of pancreatic cancer patients has ... to treatment, which is not being met by the ... contains an array of products with varying molecule types ...
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... than 200 million years ago, a massive extinction decimated ... end of the Triassic period and the onset of ... dinosaurs to dominate Earth for the next 135 million ... marine and terrestrial species. It,s not entirely clear ...
... gentler chemotherapy drug in the form of nanoparticles has been designed ... woman,s fertility but extra tough on cancer. This is the first ... using a novel in vitro test. ... that predicts the toxicity of a chemotherapy drug to fertility and ...
... WASHINGTON, D.C.--Pit latrines are one of the most common ... on the rise as countries aim to meet the ... evidence supports the use of these basic toilets as ... pit latrines can actually allow disease-causing microbes or other ...
Cached Biology News:Huge and widespread volcanic eruptions triggered the end-Triassic extinction 2Huge and widespread volcanic eruptions triggered the end-Triassic extinction 3Huge and widespread volcanic eruptions triggered the end-Triassic extinction 4New chemo drug gentler on fertility, tougher on cancer 2New chemo drug gentler on fertility, tougher on cancer 3Additional research must be done to ensure safety of pit latrines, new study says 2
(Date:7/30/2015)... DALLAS , July 30, 2015  With over 60,000 customers across the globe, ISN ... helps connect 450 hiring organizations with more than 60,000 safe and reliable contractors in over 80 ... ... ... Headquartered in Dallas, ...
(Date:7/30/2015)... 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... the second $1.0M tranche under a previously awarded ... valued at up to $3.0 million to support ... as a potential medical countermeasure to mitigate acute ... awarded an initial $1.0 million under this grant ...
(Date:7/29/2015)... Sanofi, a global and ... quarter of 2015. CEO Olivier Brandicourt ... in different businesses. Watch video interview ... Topics covered in the interview include:  ... Performance drivers - Diabetes ...
(Date:7/29/2015)... 2015 US-Australian drug discovery company, Novogen Limited ... is committed to progressing its ground-breaking technology platforms to ... to ensure the Company delivers the best value for ... Ross , said the Company currently had an extensive ... discovery programs and academic partnerships and initiatives, and he ...
Breaking Biology Technology:ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10
... WARSAW, Ind., Sept. 15 Symmetry Medical Inc.,(NYSE: ... the global,orthopedic device industry and other medical markets, announced ... is scheduled to,present at the UBS Global Life Sciences ... City on Thursday, September 25, 2008 at 11:30 a.m. ...
... Corporation,(OTC Bulletin Board: CONX), a worldwide developer and ... call on Thursday, September,25, 2008, at 4:00 PM ... for its fiscal year ended June 30, 2008, ... marketing activities., Corgenix invites all those interested ...
... 15 Epeius Biotechnologies,Corporation today announced that Rexin-G, ... been highlighted in a recent NEWS article,published by ... Sept. 9,2008). The article, authored by Vickie Brower, ... that may succeed where small,molecules and proteins have ...
Cached Biology Technology:Symmetry Medical to Present at UBS Global Life Sciences Conference 2Epeius Biotechnologies' Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal 2
Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human peripheral blood CD56+ NK cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Yeast tRNA 50 l...
Umbilical cord blood neutrophils, For immunohistochemistry (IHC)...
Biology Products: